Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.90575 | 38 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.87793 | 38 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.88166 | 39 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.78281 | 37 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.8986 | 41 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.97854 | 39 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.94268 | 38 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.85959 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.8478 | 38 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.87626 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.86131 | 38 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.85422 | 39 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.87537 | 38 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.86817 | 38 |